Wyeth To Seek Prevenar Otitis Media Indication In Future Submission
Executive Summary
Wyeth-Lederle plans to seek an indication for its pneumococcal conjugate vaccine Prevenar for the prevention of otitis media in a future submission to FDA.
You may also be interested in...
Wyeth-Lederle To Submit Monthly Adverse Events Reports For Prevnar
Wyeth-Lederle Vaccines is required to submit monthly reports of adverse events for Prevnar in its first year following approval.
Wyeth-Lederle To Submit Monthly Adverse Events Reports For Prevnar
Wyeth-Lederle Vaccines is required to submit monthly reports of adverse events for Prevnar in its first year following approval.
Wyeth Prevenar Approval Expected By End of February
Wyeth-Ayerst is expecting approval of its pneumococcal conjugate vaccine Prevenar by the end of February.